|
INTERVIEWS
|
| Myelodysplastic Syndromes
Interview with SV Gritsaev |
PDF
|
|
REVIEWS
|
| Theory and Practice of Immunotherapy Directed against the PRAME Antigen
Misyurin VA |
PDF
|
| LYMPHOID TUMORS |
| First-Line Treatment of Mantle-Cell Lymphoma: Analysis of Effectiveness and Cost-Effectiveness
Kaplanov KD, Volkov NP, Klitochenko TYu, Shipaeva AL, Matveeva IV, Shirokova MN, Proskurina AC, Red’kina NA, Gemdzhyan EG |
PDF
|
| Epstein-Barr Virus in Patients with Classical Hodgkin’s Lymphoma
Gurtsevitch VE, Demina EA, Senyuta NB, Botezatu IV, Smirnova KV, Dushen’kina TE, Maksimovich DM, Paramonova UV, Monin IS, Lichtenshtein AV |
PDF
|
| Minimal Residual Disease and IGHV-Genes Mutational Status as the Main Predictors of Response to Bendamustine-Rituximab Therapy in Previously Untreated Chronic Lymphocytic Leukemia
Mirolyubova YuV, Stadnik EA, Strugov VV, Andreeva TO, Nikulina TS, Virts YuV, Butylin PA, Rumyantsev AG, Zaritskey AYu |
PDF
|
| Evolution of Anti-Cancer Treatment and its Impact on Surrogate Prognostic Factors in Multiple Myeloma
Luchinin AS, Semochkin SV, Minaeva NV, Pozdeev NM, Paramonov IV |
PDF
|
| Polymerase Chain Reaction for Prognosis Assessment and Monitoring of the Epstein-Barr Virus-Associated Hodgkin’s Lymphoma
Katin MA, Zhil’tsov IV, Semenov VM, Novik DK |
PDF
|
|
BONE MARROW TRANSPLANTATION
|
| Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma in the Era of New Drugs
Pirogova OV, Darskaya EI, Porunova VV, Kudyasheva OV, Smirnova AG, Moiseev IS, Babenko EV, Afanas’ev BV |
PDF
|
| Hematopoietic Stem Cell Collection in Multiple Myeloma Patients: Influence of the Lenalidomide-Based Therapy and Mobilization Regimen Prior to Auto-HSCT
Kostroma II, Zhernyakova AA, Chubukina ZhV, Zapreeva IM, Tiranova SA, Sel’tser AV, Semenova NYu, Bessmel’tsev SS, Chechetkin AV, Gritsaev SV |
PDF
|
| CONGRESSES, CONFERENCES, SYMPOSIA |
| Materials of the 59th Congress of American Society of Hematology (December, 2017; Atlanta) |
PDF
|
